Repligen Corporation (RGEN) - Total Liabilities
Based on the latest financial reports, Repligen Corporation (RGEN) has total liabilities worth $840.62 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Repligen Corporation - Total Liabilities Trend (1985–2024)
This chart illustrates how Repligen Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Repligen Corporation's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Repligen Corporation Competitors by Total Liabilities
The table below lists competitors of Repligen Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Steel Authority of India Limited
NSE:SAIL
|
India | Rs755.40 Billion |
|
MITSU.CH.GRP ADR/5
F:M3C0
|
Germany | €3.28 Trillion |
|
SHIMANO INC. UNSP.ADR/10
F:SHM1
|
Germany | €68.75 Billion |
|
Shanghai Putailai New Energy Technology Co.Ltd.
SHG:603659
|
China | CN¥26.89 Billion |
|
Corporacion Acciona Energias Renovables SA
MC:ANE
|
Spain | €8.54 Billion |
|
Tetra Tech Inc
NASDAQ:TTEK
|
USA | $2.50 Billion |
|
Sprouts Farmers Market LLC
NASDAQ:SFM
|
USA | $2.84 Billion |
|
The Magnum Ice Cream Company N.V.
AS:MICC
|
Netherlands | €6.86 Billion |
Liability Composition Analysis (1985–2024)
This chart breaks down Repligen Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see RGEN current and non-current assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.36 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Repligen Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Repligen Corporation (1985–2024)
The table below shows the annual total liabilities of Repligen Corporation from 1985 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $856.95 Million | +0.44% |
| 2023-12-31 | $853.21 Million | +37.41% |
| 2022-12-31 | $620.90 Million | +2.07% |
| 2021-12-31 | $608.29 Million | +62.76% |
| 2020-12-31 | $373.74 Million | +9.81% |
| 2019-12-31 | $340.35 Million | +113.98% |
| 2018-12-31 | $159.05 Million | +4.70% |
| 2017-12-31 | $151.92 Million | +26.44% |
| 2016-12-31 | $120.15 Million | +411.51% |
| 2015-12-31 | $23.49 Million | +41.83% |
| 2014-12-31 | $16.56 Million | +12.21% |
| 2013-12-31 | $14.76 Million | +14.54% |
| 2012-12-31 | $12.89 Million | +27.58% |
| 2011-12-31 | $10.10 Million | +93.96% |
| 2010-12-31 | $5.21 Million | 0.00% |
| 2009-12-31 | $5.21 Million | -1.74% |
| 2008-12-31 | $5.30 Million | +14.43% |
| 2007-12-31 | $4.63 Million | -2.15% |
| 2006-12-31 | $4.73 Million | +33.79% |
| 2005-12-31 | $3.54 Million | +11.73% |
| 2004-12-31 | $3.17 Million | -4.56% |
| 2003-12-31 | $3.32 Million | +18.17% |
| 2002-12-31 | $2.81 Million | +25.14% |
| 2001-12-31 | $2.24 Million | -15.88% |
| 2000-12-31 | $2.67 Million | +112.18% |
| 1999-12-31 | $1.26 Million | +4.99% |
| 1998-12-31 | $1.20 Million | +199.27% |
| 1997-12-31 | $400.00K | +33.33% |
| 1996-12-31 | $300.00K | -62.50% |
| 1995-12-31 | $800.00K | -94.90% |
| 1994-12-31 | $15.70 Million | +23.62% |
| 1993-12-31 | $12.70 Million | +4.10% |
| 1992-12-31 | $12.20 Million | +64.86% |
| 1991-12-31 | $7.40 Million | +164.29% |
| 1990-12-31 | $2.80 Million | +7.69% |
| 1989-12-31 | $2.60 Million | -23.53% |
| 1988-12-31 | $3.40 Million | +21.43% |
| 1987-12-31 | $2.80 Million | +12.00% |
| 1986-12-31 | $2.50 Million | +38.89% |
| 1985-12-31 | $1.80 Million | -- |
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-pack… Read more